Martin Shkreli returns to livestreams, offering controversial stock tips

Martin Shkreli, previously convicted for defrauding investors and notorious for inflating the price of the antiparasitic drug Daraprim, has resumed a public presence by hosting daily YouTube livestreams. In these hours‑long broadcasts he delivers off‑the‑cuff analyses of numerous companies, promotes his financial‑software venture Godel as a cheaper alternative to the Bloomberg Terminal, and serves as an adviser to a micro‑cap optical‑computing firm. Shkreli’s commentary includes provocative language, short‑selling of SpaceX and claims that he enjoys provoking large numbers of people on the X platform.

His online activity coincides with a broader surge in retail speculation and a deregulation climate linked to the Trump administration’s return to power, which has reduced consumer protections and heightened market volatility. Shkreli’s stock calls have reportedly moved some shares by as much as 40 percent.